Company News

Alpha Omega Nazareth, Israel has won the Eagle Star award for the “2012 American Israeli Company of the Year”


Nazareth – June 25, 2012 – On June 12, 2012 Alpha Omega was presented the award as the “2012 American Israeli Company of the Year” by the American Israeli Chamber of Commerce in Atlanta, Georgia.


Alpha Omega has been operating in Atlanta for over a decade and contributing to the development of the U.S. economy. The judges were impressed with many of Alpha Omega achievements. Comments from the judges included: “Alpha Omega Technology has improved the quality of life for thousands of patients around the world” and, “Alpha Omega exemplifies the diversity of Israel with technology developed in the country’s top universities, combining the expertise of Arabs, Jews, Christians and Muslims from different nationalities working together to fulfill a challenging mission”.
“We are very proud with the achievements we have made throughout the past years, and it is our goal to continue advancing the quality of neurology and neurosurgery patient care by developing superior technology solutions”, said Mr. Imad Younis, President.
 

About Alpha Omega
Alpha Omega (www.alphaomega-eng.com) is a global company with an extensive customer base worldwide, serving hospitals and universities in development of both neuroscience research and functional neurosurgery instruments that treat various neurological disorders affecting countless individuals.
 

-end-
 

--------------------------------------------------------------------------------------------------------------------------

 

Alpha Omega Nazareth, Israel has named Anthony DeCarolis as CEO of Alpha Omega USA headquartered in Atlanta, Georgia

 

Nazareth – June 13, 2012 – The appointment was effective June 1st as Mr. DeCarolis assumes responsibility for Alpha Omega operations. Alpha Omega USA sales are the largest of Alpha Omega worldwide sales.
 

Mr. Decarolis has held positions as President and CEO of Elekta Inc., and senior positions with GE Medical Systems, Toshiba Medical Systems and board positions with private equity groups.
 

“Alpha Omega competes in a rapidly growing market and is taking a leading role in Deep Brain Stimulation enabling technology. Mr. DeCarolis’ vast business experience and leadership will contribute considerably in successfully implementing our strategy and taking advantage of the market opportunities ahead” said Mr. Imad Younis, President.
 

About Alpha Omega
Alpha Omega (www.alphaomega-eng.com) is a global company with an extensive customer base worldwide, serving hospitals and universities in development of both neuroscience research and functional neurosurgery instruments that treat various neurological disorders affecting countless individuals.

-end-